Chimeric Therapeutics is trading 18.18% down at A$0.01 after unexplained selling during the September 3, 2026 session.
- No verified company-specific announcement or trading halt directly explaining the decline was identified.
- A September 4 filing reported an application to quote 14,814,814 new ordinary shares, but available reporting does not establish that it caused the selloff.
- Broader markets were firm, providing limited macro explanation.